Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.87 Analyst target: $22.67 Upside: 2505.45%
IceCure Medical Ltd develops and markets minimally invasive cryoablation therapies for the women's health and oncology markets. The company is headquartered in Caesarea, Israel.
See the full interactive analysis & chart →Informational only — not investment advice.